MRI study comparing blood thinners after a certain stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial looks at MRI scans to compare two types of blood-thinning medicines (one that affects blood-clotting and one that affects platelets) after a recent stroke caused by severe narrowing in certain brain arteries. It may help doctors understand which treatment works best while checking how the blood vessels and brain tissue look on MRI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must already be enrolled in the CAPTIVA stroke trial
- Your stroke must have happened within the last 30 days and not have caused lasting severe disability
- Your stroke needs to be linked to 70–99% narrowing in specific brain arteries (ICA, MCA, BA, or VA)
- You must be able to get a baseline MRI within 14 days of starting CAPTIVA
- You must be able and willing to have MRI scans (no MRI safety problems like certain pacemakers)
- You must not have a gadolinium contrast allergy and must not have very poor kidney function (eGFR under 30)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special brain MRI to look closely at plaque in certain brain arteries after an ischemic stroke (when a blood vessel is blocked). It may help researchers better understand which plaques are most dangerous soon after stroke.
This study investigates the build-up of fatty deposits called plaques in arteries of the brain and neck using two different strengths of MRI scanners. It aims to understand how well these MRI techniques can image the plaques, which could help doctors better diagnose and manage stroke risk.
This trial compares two imaging tests, MRI and CT scan, to see which is better at diagnosing a severe stroke caused by a blocked large artery in the brain. If you are eligible, you would receive one of these scans to help guide your treatment.
This trial looks at how well a catheter-based procedure (endovascular treatment) works for people with a severely narrowed brain artery that has already caused a mini-stroke or stroke. The goal is to prevent future strokes.
This study uses a special MRI scan to look at the blood vessels in the brain to help doctors tell whether a stroke was caused by hardening of the arteries or by inflammation. This may help guide better treatment.
This study tests whether a combination of two blood-thinning medications (clopidogrel and rivaroxaban) is better than standard treatment (aspirin alone or aspirin plus clopidogrel) for preventing another stroke in people who have a narrowed artery inside the brain. It aims to reduce the risk of future strokes while managing bleeding risks.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.